Literature DB >> 8592944

Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.

M Kanatani1, T Sugimoto, H Kaji, T Kobayashi, K Nishiyama, M Fukase, M Kumegawa, K Chihara.   

Abstract

Although the action of bone morphogenetic protein (BMP) on osteoblast differentiation has been extensively investigated, its effect on osteoclast differentiation remains unknown. In the present study, in vitro effects of BMP-2 on osteoclast-like cell formation and bone resorption were examined. BMP-2 (1-100 ng/ml) significantly stimulated bone resorption by preexistent osteoclast-like cells in mouse bone cell cultures containing stromal cells, whereas it did not affect the bone-resorbing activity of isolated rabbit osteoclast-like cells. When BMP-2 was added to unfractionated bone cells after degeneration of preexistent osteoclast-like cells, BMP-2 dose-dependently stimulated osteoclast-like formation at a minimal effective concentration of 10 pg/ml. BMP-2 also enhanced the osteoclast-like cell formation induced by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). Moreover, osteoclast-like cells newly formed by BMP-2 from unfractionated bone cells possessed the ability to form pits on dentine slices. Because these results indicated that BMP-2 directly or indirectly stimulated osteoclast differentiation and activity, we next examined the direct effect of BMP-2 on osteoclast precursors in the absence of stromal cells using hemopoietic blast cells derived from spleen cells. The mRNA for BMP-2/4 receptor was detected in hemopoietic blast cells supported by granulocyte-macrophage colony-stimulating factor (GM-CSF) as well as osteoblastic MC3T3-E1 cells and MC3T3-G2/PA6 stromal cells by RNase protection assay. BMP-2 dose-dependently stimulated osteoclast-like cell formation from hemopoietic blast cells supported by GM-CSF at a minimal effective concentration of 10 pg/ml. BMP-2 also enhanced 1,25(OH)2D3-induced osteoclast-like formation from hemopoietic blast cells. The present data are the first to indicate that BMP-2 stimulates bone resorption through both direct stimulation of osteoclast formation and activation of mature osteoclasts, possibly via stomal cells, in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592944     DOI: 10.1002/jbmr.5650101110

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  32 in total

Review 1.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

Review 2.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Authors:  Slobodan Vukicevic; Hermann Oppermann; Donatella Verbanac; Morana Jankolija; Irena Popek; Jasna Curak; Jelena Brkljacic; Martina Pauk; Igor Erjavec; Igor Francetic; Ivo Dumic-Cule; Mislav Jelic; Dragan Durdevic; Tomislav Vlahovic; Ruder Novak; Vera Kufner; Tatjana Bordukalo Niksic; Marija Kozlovic; Zrinka Banic Tomisic; Jadranka Bubic-Spoljar; Ivancica Bastalic; Smiljka Vikic-Topic; Mihaela Peric; Marko Pecina; Lovorka Grgurevic
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

Review 3.  Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures.

Authors:  Amin Bigham-Sadegh; Ahmad Oryan
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

4.  Effect of bone morphogenetic protein 2 on tendon-to-bone healing in a canine flexor tendon model.

Authors:  Stavros Thomopoulos; H Mike Kim; Matthew J Silva; Eleni Ntouvali; Cionne N Manning; Ryan Potter; Howard Seeherman; Richard H Gelberman
Journal:  J Orthop Res       Date:  2012-05-22       Impact factor: 3.494

5.  Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues.

Authors:  Masato Yano; Naoyuki Kawao; Katsumi Okumoto; Yukinori Tamura; Kiyotaka Okada; Hiroshi Kaji
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

Review 6.  A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.

Authors:  Aaron W James; Gregory LaChaud; Jia Shen; Greg Asatrian; Vi Nguyen; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Tissue Eng Part B Rev       Date:  2016-04-19       Impact factor: 6.389

7.  Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis.

Authors:  Aaron Broege; Lan Pham; Eric D Jensen; Ann Emery; Tsang-Hai Huang; Melissa Stemig; Hideyuki Beppu; Anna Petryk; Michael O'Connor; Kim Mansky; Raj Gopalakrishnan
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

8.  Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro.

Authors:  Wei Zhu; Jaehon Kim; Christina Cheng; Bernard A Rawlins; Oheneba Boachie-Adjei; Ronald G Crystal; Chisa Hidaka
Journal:  Bone       Date:  2006-02-20       Impact factor: 4.398

9.  Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.

Authors:  Michihiko Usui; Lianping Xing; Hicham Drissi; Michael Zuscik; Regis O'Keefe; Di Chen; Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

10.  Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures.

Authors:  Neil Ghodadra; Kern Singh
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.